Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2020-09-15 2020-09-15
Drug Identification Number 02242528 02242528
Brand name SANDOZ PROCTOMYXIN HC SUPPOSITORIES SANDOZ PROCTOMYXIN HC SUPPOSITORIES
Common or Proper name SANDOZ PROCTOMYXIN HC SUPPOSITOIRES SANDOZ PROCTOMYXIN HC SUPPOSITOIRES
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients DIBUCAINE HYDROCHLORIDE ESCULIN HYDROCORTISONE FRAMYCETIN SULFATE DIBUCAINE HYDROCHLORIDE ESCULIN HYDROCORTISONE FRAMYCETIN SULFATE
Strength(s) 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG
Dosage form(s) SUPPOSITORY SUPPOSITORY
Route of administration RECTAL RECTAL RECTAL RECTAL
Packaging size 12SUP ST V1 CA 12SUP ST V1 CA
ATC code C05AA C05AA
ATC description AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-09-11 2020-09-11
Estimated end date 2020-10-09 2020-10-09
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments